Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

The mixed earnings report comes on the heels of the Abbott Park, IL-based company announcing it would acquire Exact Sciences for $21 billion.

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

Dexcom achieved FY25 revenues of around $4.66bn, corresponding to a 16% uplift over FY24.

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and your fit-fluencer friend. Jake Leach, who took over as Dexcom CEO today, wants ...

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...

Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland.

Type 2 diabetes is not reversible, but it can go into remission, meaning your blood sugar levels return to normal without medication for at least three months. Some people can achieve this by ...

The mean, variance, and autocorrelation of glucose dynamics are independently associated with coronary plaque vulnerability.

Senseonics and Sequel MedTech have launched the integration of their products with the first patients receiving a Sequel twiist automated insulin delivery (AID) system paired with the implantable ...